BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 29958022)

  • 1. Adaptability of Closed Loop During Labor, Delivery, and Postpartum: A Secondary Analysis of Data from Two Randomized Crossover Trials in Type 1 Diabetes Pregnancy.
    Stewart ZA; Yamamoto JM; Wilinska ME; Hartnell S; Farrington C; Hovorka R; Murphy HR
    Diabetes Technol Ther; 2018 Jul; 20(7):501-505. PubMed ID: 29958022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
    Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
    Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.
    Stewart ZA; Wilinska ME; Hartnell S; Temple RC; Rayman G; Stanley KP; Simmons D; Law GR; Scott EM; Hovorka R; Murphy HR
    N Engl J Med; 2016 Aug; 375(7):644-54. PubMed ID: 27532830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Trial of Closed-Loop Insulin Delivery Postpartum in Type 1 Diabetes.
    Donovan LE; Feig DS; Lemieux P; Murphy HR; Bell RC; Sigal RJ; Ho J; Virtanen H; Crawford S; Yamamoto JM
    Diabetes Care; 2023 Dec; 46(12):2258-2266. PubMed ID: 37824779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Software-guided insulin dosing improves intrapartum glycemic management in women with diabetes mellitus.
    Dinglas C; Muscat J; Adams T; Peragallo-Dittko V; Vintzileos A; Heo HJ
    Am J Obstet Gynecol; 2018 Aug; 219(2):191.e1-191.e6. PubMed ID: 29750952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.
    Lee TTM; Collett C; Bergford S; Hartnell S; Scott EM; Lindsay RS; Hunt KF; McCance DR; Barnard-Kelly K; Rankin D; Lawton J; Reynolds RM; Flanagan E; Hammond M; Shepstone L; Wilinska ME; Sibayan J; Kollman C; Beck R; Hovorka R; Murphy HR;
    N Engl J Med; 2023 Oct; 389(17):1566-1578. PubMed ID: 37796241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial.
    Nimri R; Muller I; Atlas E; Miller S; Fogel A; Bratina N; Kordonouri O; Battelino T; Danne T; Phillip M
    Diabetes Care; 2014 Nov; 37(11):3025-32. PubMed ID: 25078901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial.
    Tauschmann M; Allen JM; Nagl K; Fritsch M; Yong J; Metcalfe E; Schaeffer D; Fichelle M; Schierloh U; Thiele AG; Abt D; Kojzar H; Mader JK; Slegtenhorst S; Barber N; Wilinska ME; Boughton C; Musolino G; Sibayan J; Cohen N; Kollman C; Hofer SE; Fröhlich-Reiterer E; Kapellen TM; Acerini CL; de Beaufort C; Campbell F; Rami-Merhar B; Hovorka R;
    Diabetes Care; 2019 Apr; 42(4):594-600. PubMed ID: 30692242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.
    Hovorka R; Allen JM; Elleri D; Chassin LJ; Harris J; Xing D; Kollman C; Hovorka T; Larsen AM; Nodale M; De Palma A; Wilinska ME; Acerini CL; Dunger DB
    Lancet; 2010 Feb; 375(9716):743-51. PubMed ID: 20138357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study.
    Drever E; Tomlinson G; Bai AD; Feig DS
    Diabet Med; 2016 Sep; 33(9):1253-9. PubMed ID: 26927202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol.
    Musolino G; Allen JM; Hartnell S; Wilinska ME; Tauschmann M; Boughton C; Campbell F; Denvir L; Trevelyan N; Wadwa P; DiMeglio L; Buckingham BA; Weinzimer S; Acerini CL; Hood K; Fox S; Kollman C; Sibayan J; Borgman S; Cheng P; Hovorka R
    BMJ Open; 2019 Jun; 9(6):e027856. PubMed ID: 31164368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study.
    Leelarathna L; Dellweg S; Mader JK; Allen JM; Benesch C; Doll W; Ellmerer M; Hartnell S; Heinemann L; Kojzar H; Michalewski L; Nodale M; Thabit H; Wilinska ME; Pieber TR; Arnolds S; Evans ML; Hovorka R;
    Diabetes Care; 2014 Jul; 37(7):1931-7. PubMed ID: 24963110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial.
    Hovorka R; Elleri D; Thabit H; Allen JM; Leelarathna L; El-Khairi R; Kumareswaran K; Caldwell K; Calhoun P; Kollman C; Murphy HR; Acerini CL; Wilinska ME; Nodale M; Dunger DB
    Diabetes Care; 2014; 37(5):1204-11. PubMed ID: 24757227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies.
    Hovorka R; Kumareswaran K; Harris J; Allen JM; Elleri D; Xing D; Kollman C; Nodale M; Murphy HR; Dunger DB; Amiel SA; Heller SR; Wilinska ME; Evans ML
    BMJ; 2011 Apr; 342():d1855. PubMed ID: 21493665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes.
    Murphy HR; Elleri D; Allen JM; Harris J; Simmons D; Rayman G; Temple R; Dunger DB; Haidar A; Nodale M; Wilinska ME; Hovorka R
    Diabetes Care; 2011 Feb; 34(2):406-11. PubMed ID: 21216859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial.
    Daly AB; Boughton CK; Nwokolo M; Hartnell S; Wilinska ME; Cezar A; Evans ML; Hovorka R
    Nat Med; 2023 Jan; 29(1):203-208. PubMed ID: 36631592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.